Physician
Pathology
Dr. John C. Hiserodt, MD
|
|
Give Review
John C. Hiserodt practices Pathology. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a one of the best medicals schools. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine John Hiserodt is also a published doctor. He has 92 paper published. The most recent paper is: Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human... Doctor John C. Hiserodt, MD is registered with Medicare.
Publications
- Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-st...
- Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro.
- Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human...
- The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer.
- Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human ...
- Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer.
- In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA).
- Lymphocyte and monocyte-induced motility of MCF-7 cells by tumor necrosis factor-alpha.
- Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix.
- Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat.
- The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes prone BB rat.
- Effects of irradiation on the expression of surface antigens in human ovarian cancer.
- Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer.
- Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules.
- Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in...
- CD8+ T-cells are required for adoptive transfer of the BB rat diabetic syndrome.
- Lymphokine-activated killer cells: biology and relevance to disease.
- NKR-P1+ cells in the rat uterus: granulated metrial gland cells are of the natural killer cell lineage.
- Development and characterization of an IL-4-secreting human ovarian carcinoma cell line.
- A comparison of blood lipid and lipoprotein values in young adults who die suddenly and unexpectedly from atherosclerotic coronary artery disease with other noncardiac...
- Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells.
- Inhibition of human natural killing by heterologous and monoclonal antibodies.
- Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" al...
- A "nonidiotypic" inhibition of influenza-immune H-2-restricted CTL by an anti-T cell serum.
- Blocking of the induction and expression of immunologically functional T lymphocytes by rat antiactivated T-cell serum.
- Studies on the induction and expression of T-cell-mediated immunity. XIII. Membrane-associated antigens of cytotoxic T lymphocytes involved in cytotoxicity.
- Characterization of antibody-mediated inhibition of natural killer (NK) cytotoxicity: evidence for blocking of both recognition and lethal hit stages of cytolysis.
- Studies on the mechanism of the human natural killer cell lethal hit: evidence for transfer of protease-sensitive structures requisite for target cell lysis.
- Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
- Studies on the mechanism of the human natural killer cell lethal hit: a new method for rapid physical isolation of lethally hit K562 targets and inhibition of cytolysi...
- Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming fo...
- Molecular interactions in T-cell-mediated cytotoxicity.
- Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps.
- Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum m...
- Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells.
- The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease.
- Laminin production by murine melanoma cells: possible involvement in cell motility.
- Is there evidence for transfer of materials from the killer cell to the target requisite for target cell lysis?
- The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
- In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells.
- A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.
- Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated kill...
- Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
- Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
- Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lympho...
- Reduced natural killer cell activity in patients with systemic sclerosis. Correlation with clinical disease type.
- Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of bl...
- Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation.
- Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity.
- Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes.
- Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
- In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
- Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes.
- A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the leth...
- Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells.
- Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation.
- The importance of splenectomy for the adoptive immunotherapy of cancer.
- Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic.
- Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
- Natural killer cells and tumor immunity.
- Mechanisms of target cell killing by natural killer cells.
- Natural killer cells and tumor immunity: 1987.
- Inhibition of neutrophil and natural killer cell function by human seminal fluid acid phosphatase.
- Laminin receptor expression on murine tumor cells: correlation with sensitivity to natural cell-mediated cytotoxicity.
- Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
- Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo.
- Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas.
- NKR-P1, a signal transduction molecule on natural killer cells.
- Natural cell-mediated immunity in the rabbit.
- In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor-bearing rats.
- The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures.
- Effects of splenectomy on the development of tumor-specific immunity.
- In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats.
- Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms.
- The cytotoxic action of OK-432 from Streptococcus pyogenes.
- Effect of selective depletion of natural killer cells on allograft rejection.
- NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
- In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats.
- Some thoughts on the cytolytic mechanism of natural killer lymphocytes.
- Effects of in vivo treatment with FK506 on natural killer cells in rats.
- Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat.
- Identification and partial characterization of a novel plasma membrane-associated lytic factor isolated from highly purified adherent lymphokine-activated killer cells.
- Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism.
- Distribution of lymphocyte subsets in rat milk from normal and Trichinella spiralis-infected rats.
- In vivo induced allo-reactive natural killer cells.
- The human LT system. VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and ...
- The LT system in experimental animals. IV. Rapid specific lysis of 51CR-labeled allogeneic target cells by highly unstable high m.w. lymphotoxin-receptor complex(es) r...
- The LT system in experimental animals. III. Physicochemical characteristics and relationships of lymphotoxin (LT) molecules released in vitro by activated lymphoid cel...
- The LT system in experimental animals. II. Physical and immunologic characteristics of molecules with LT activity rapidly released by murine lymphoid cells activated o...
- The LT system in experimental animals. I. Rapid release of high levels of lymphotoxin (LT) activity from murine lymphocytes during the interaction with lectin-treated ...
- The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysi...
Schools
University of California At Los Angeles
University Mi Hospital
Allegheny Co Coroners Off
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Education
-
University of Michigan Hospitals and Health Centers -
David Geffen School of Medicine at UCLA
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235296864 |
| Last Name Of The Provider | HISERODT |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Usha Dhar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahim Karjoo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald P. Sharkoff, MD
This Doctor is OpenDoctor Recommended.
|